actabiomedicaActa Biomedica ScientificaActa Biomedica Scientifica2541-94202587-9596Scientific Centre for Family Health and Human Reproduction Problems10.29413/ABS.2020-5.6.8actabiomedica-2497Research ArticleДИСКУССИОННЫЕ СТАТЬИ, ЛЕКЦИИ, НОВЫЕ ТРЕНДЫ МЕДИЦИНСКОЙ НАУКИDISCUSSION PAPERS, LECTURES, NEW TRENDS IN MEDICAL SCIENCEКлеточные технологии в травматологии: от клетки до тканевой инженерииCellular Technologies in Traumatology: from Cells to Tissue Engineeringhttps://orcid.org/0000-0002-2540-4525ДреминаН. Н.DreminaN. N.

кандидат биологических наук, старший научный сотрудник лаборатории клеточных технологий и регенеративной медицины

664003, г. Иркутск, ул. Борцов Революции, 1, Россия

Cand. Sc. (Biol.), Senior Research Officer at the Laboratory of Cell Technologies and Regenerative Medicine

Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation

drema76@mail.ruhttps://orcid.org/0000-0002-0270-404XТруханИ. С.TrukhanI. S.

Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation

predel4@yandex.ruhttps://orcid.org/0000-0003-3980-050XШурыгинаИ. А.ShuryginaI. A.

Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation

irinashurygina@gmail.comФГБНУ «Иркутский научный центр хирургии и травматологии»Irkutsk Scientific Centre of Surgery and Traumatology202014012021566676Copyright &#x00A9; Дремина Н.Н., Трухан И.С., Шурыгина И.А., 20212021Дремина Н.Н., Трухан И.С., Шурыгина И.А.Dremina N.N., Trukhan I.S., Shurygina I.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.actabiomedica.ru/jour/article/view/2497клеточные технологиимезенхимальные стволовые клеткирепарациятравматологиякостьхрящсell technologiesmesenchymal stem cellsreparationtraumatologybonecartilageReferencesYorukoglu AC, Kiter AE, Akkaya S, Satiroglu-Tufan NL, Tufan AC. A concise review on the use of mesenchymal stem cells in cell sheet-based tissue engineering with special emphasis on bone tissue regeneration. Stem Cells Int. 2017; 2017: 2374161. doi: 10.1155/2017/2374161Yorukoglu AC, Kiter AE, Akkaya S, Satiroglu-Tufan NL, Tufan AC. A concise review on the use of mesenchymal stem cells in cell sheet-based tissue engineering with special emphasis on bone tissue regeneration. Stem Cells Int. 2017; 2017: 2374161. doi: 10.1155/2017/2374161Bhardwaj N, Chouhan D, Mandal BB. Tissue engineered skin and wound healing: Current strategies and future directions. Curr Pharm Des. 2017; 23(24): 3455-3482. doi: 10.2174/1381612823666170526094606Bhardwaj N, Chouhan D, Mandal BB. Tissue engineered skin and wound healing: Current strategies and future directions. Curr Pharm Des. 2017; 23(24): 3455-3482. doi: 10.2174/1381612823666170526094606Tarassoli SP, Jessop ZM, Al-Sabah A, Gao N, Whitaker S, Doak S, Whitaker IS. Skin tissue engineering using 3D bioprinting: An evolving research field. Plast Reconstr Aesthet Surg. 2018; 71(5): 615-623. doi: 10.1016/j.bjps.2017.12.006Tarassoli SP, Jessop ZM, Al-Sabah A, Gao N, Whitaker S, Doak S, Whitaker IS. Skin tissue engineering using 3D bioprinting: An evolving research field. Plast Reconstr Aesthet Surg. 2018; 71(5): 615-623. doi: 10.1016/j.bjps.2017.12.006Modugno FD, Colosi C, Trono P, Antonacci G, Ruocco G, Nisticò P. 3D models in the new era of immune oncology: focus on T cells, CAF and ECM. J Exp Clin Cancer Res. 2019; 38(1): 117. doi: 10.1186/s13046-019-1086-2Modugno FD, Colosi C, Trono P, Antonacci G, Ruocco G, Nisticò P. 3D models in the new era of immune oncology: focus on T cells, CAF and ECM. J Exp Clin Cancer Res. 2019; 38(1): 117. doi: 10.1186/s13046-019-1086-2Schmidt SK, Schmid R, Arkudas A, Kengelbach-Weigand A, Bosserhoff AK. Tumor cells develop defined cellular phenotypes after 3D-bioprinting in different bioinks. Cells. 2019; 8(10): 1295. doi: 10.3390/cells8101295Schmidt SK, Schmid R, Arkudas A, Kengelbach-Weigand A, Bosserhoff AK. Tumor cells develop defined cellular phenotypes after 3D-bioprinting in different bioinks. Cells. 2019; 8(10): 1295. doi: 10.3390/cells8101295Sun Q, Barz M, De Geest BG, Diken M, Hennink WE, Kiessling F, Lammers T, Shi Y. Nanomedicine and macroscale materials in immuno-oncology. Chem Soc Rev. 2019; 48(1): 351-381. doi: 10.1039/c8cs00473kSun Q, Barz M, De Geest BG, Diken M, Hennink WE, Kiessling F, Lammers T, Shi Y. Nanomedicine and macroscale materials in immuno-oncology. Chem Soc Rev. 2019; 48(1): 351-381. doi: 10.1039/c8cs00473kShevchenko IL. Cellular technologies in cardiology. Vestn Ross Akad Med Nauk. 2003; 11: 6-10.Shevchenko IL. Cellular technologies in cardiology. Vestn Ross Akad Med Nauk. 2003; 11: 6-10.Duran AG, Reidell O, Stachelscheid H, Klose K, Gossen M, Falk V, Röll W, Stamm C. Regenerative medicine/cardiac cell therapy: Pluripotent stem cells. Thorac Cardiovasc Surg. 2018; 66(1): 53-62. doi: 10.1055/s-0037-1608761Duran AG, Reidell O, Stachelscheid H, Klose K, Gossen M, Falk V, Röll W, Stamm C. Regenerative medicine/cardiac cell therapy: Pluripotent stem cells. Thorac Cardiovasc Surg. 2018; 66(1): 53-62. doi: 10.1055/s-0037-1608761Goradel NH, Ghiyami-Hour F, Negahdari B, Malekshahi ZV, Hashemzehi M, Masoudifar A, Mirzaei H. Stem cell therapy: A new therapeutic option for cardiovascular diseases. J Cell Biochem. 2018; 119(1): 95-104. doi: 10.1002/jcb.26169Goradel NH, Ghiyami-Hour F, Negahdari B, Malekshahi ZV, Hashemzehi M, Masoudifar A, Mirzaei H. Stem cell therapy: A new therapeutic option for cardiovascular diseases. J Cell Biochem. 2018; 119(1): 95-104. doi: 10.1002/jcb.26169Taoufik E, Kouroupi G, Zygogianni O, Matsas R. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models. Open Biol. 2018; 8(9): 180138. doi: 10.1098/rsob.180138Taoufik E, Kouroupi G, Zygogianni O, Matsas R. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models. Open Biol. 2018; 8(9): 180138. doi: 10.1098/rsob.180138Nuñez J, Vignoletti F, Caffesse RG, Sanz M. Cellular therapy in periodontal regeneration. Periodontol 2000. 2019; 79(1): 107-116. doi: 10.1111/prd.12250Nuñez J, Vignoletti F, Caffesse RG, Sanz M. Cellular therapy in periodontal regeneration. Periodontol 2000. 2019; 79(1): 107-116. doi: 10.1111/prd.12250Shan LH, An XY, Xu MM, Fan SP, Zhong H, Ni P, Chi H. Analysis on the trend of innovation and development in the field of ophthalmology. Zhonghua Yan Ke Za Zhi. 2018; 54(6): 452-463. doi: 10.3760/cma.j.issn.0412-4081.2018.06.012Shan LH, An XY, Xu MM, Fan SP, Zhong H, Ni P, Chi H. Analysis on the trend of innovation and development in the field of ophthalmology. Zhonghua Yan Ke Za Zhi. 2018; 54(6): 452-463. doi: 10.3760/cma.j.issn.0412-4081.2018.06.012Millman JR, Pagliuca FW. Autologous pluripotent stem cell-derived β-like cells for diabetes cellular therapy. Diabetes. 2017; 66(5): 1111-1120. doi: 10.2337/db16-1406Millman JR, Pagliuca FW. Autologous pluripotent stem cell-derived β-like cells for diabetes cellular therapy. Diabetes. 2017; 66(5): 1111-1120. doi: 10.2337/db16-1406Arber C, Lovejoy C, Wray S. Stem cell models of Alzheimer’s disease: Progress and challenges. Alzheimers Res Ther. 2017; 9(1): 42. doi: 10.1186/s13195-017-0268-4Arber C, Lovejoy C, Wray S. Stem cell models of Alzheimer’s disease: Progress and challenges. Alzheimers Res Ther. 2017; 9(1): 42. doi: 10.1186/s13195-017-0268-4Акопян А.С., Белоусов Д.Ю., Рысулы М.Р., Куликов А.В. Некоторые актуальные проблемы клинических исследований стволовых клеток. Качественная клиническая практика. 2010; (1): 22-28.Akopyan AS, Belousov DYu, Rysuly MR, Kulikov AV. Some current problems of stem cell clinical research. Kachestvennaya klinicheskaya praktika. 2010; (1): 22-28. (In Russ.)Miguel-Beriain I. The ethics of stem cells revisited. Adv Drug Deliv Rev. 2015; 82-83: 176-80. doi: 10.1016/j.addr.2014.11.011Miguel-Beriain I. The ethics of stem cells revisited. Adv Drug Deliv Rev. 2015; 82-83: 176-80. doi: 10.1016/j.addr.2014.11.011Lavazza A, Massimini M. Cerebral organoids: ethical issues and consciousness assessment. J Med Ethics. 2018; 44(9): 606-610. doi: 10.1136/medethics-2017-104555Lavazza A, Massimini M. Cerebral organoids: ethical issues and consciousness assessment. J Med Ethics. 2018; 44(9): 606-610. doi: 10.1136/medethics-2017-104555Petrini C. Bioethics of clinical applications of stem cells. Int J Mol Sci. 2017; 18(4): 814. doi: 10.3390/ijms18040814Petrini C. Bioethics of clinical applications of stem cells. Int J Mol Sci. 2017; 18(4): 814. doi: 10.3390/ijms18040814Zheng YL. Some ethical concerns about human induced pluripotent stem cells. Sci Eng Ethics. 2016; 22(5): 1277-1284. doi: 10.1007/s11948-015-9693-6Zheng YL. Some ethical concerns about human induced pluripotent stem cells. Sci Eng Ethics. 2016; 22(5): 1277-1284. doi: 10.1007/s11948-015-9693-6Aulisio MP. Double effect, principle or doctrine of. In: Jennings B. (editor) Bioethics. Gale: Farminton Hills, MI, USA. 2014; 2: 889-894.Aulisio MP. Double effect, principle or doctrine of. In: Jennings B. (editor) Bioethics. Gale: Farminton Hills, MI, USA. 2014; 2: 889-894.Деев Р.В., Исаев А.А., Кочиш А.Ю., Тихилов P.M. Клеточные технологии в травматологии и ортопедии: пути развития. Клеточная трансплантология и тканевая инженерия. 2007; 2(4): 18-30.Deev RV, Isaev AA, Kochish AY, Tikhilov RM. Cellular technologies in traumatology and orthopedics: ways of development. Kletochnaya transplantologiya i tkanevaya inzheneriya. 2007; 2(4): 18-30. (In Russ.)Mills LA, Aitken SA, Simpson RWAH. The risk of nonunion per fracture: Current myths and revised figures from a population of over 4 million adults. Acta Orthop. 2017; 88(4): 434-439. doi: 10.1080/17453674.2017.1321351Mills LA, Aitken SA, Simpson RWAH. The risk of non-union per fracture: Current myths and revised figures from a population of over 4 million adults. Acta Orthop. 2017; 88(4): 434-439. doi: 10.1080/17453674.2017.1321351Gómez-Barrena E, Rosset P, Lozano D, Stanovici J, Ermthaller C, Gerbhard F. Bone fracture healing: Cell therapy in delayed unions and nonunions. Bone. 2015; 70: 93-101. doi: 10.1016/j.bone.2014.07.033Gómez-Barrena E, Rosset P, Lozano D, Stanovici J, Ermthaller C, Gerbhard F. Bone fracture healing: Cell therapy in delayed unions and nonunions. Bone. 2015; 70: 93-101. doi: 10.1016/j.bone.2014.07.033Fernández-Hernández O. Terapias para el hueso: Sustitutivos óseos. Mon Act Soc Esp Med Cir Pie Tobillo. 2017; 9: 45-53.Fernández-Hernández O. Terapias para el hueso: Sustitutivos óseos. Mon Act Soc Esp Med Cir Pie Tobillo. 2017; 9: 45-53.Kemper N, Davison N, Fitzpatrick D, Marshall R, Lin A, Mundy K, Cobb RR. Characterization of the mechanical properties of bovine cortical bone treated with a novel tissue sterilization process. Cell Tissue Bank. 2011; 12(4): 273-279. doi: 10.1007/s10561-010-9191-7Kemper N, Davison N, Fitzpatrick D, Marshall R, Lin A, Mundy K, Cobb RR. Characterization of the mechanical properties of bovine cortical bone treated with a novel tissue sterilization process. Cell Tissue Bank. 2011; 12(4): 273-279. doi: 10.1007/s10561-010-9191-7Mayer Y, Ginesin O, Khutaba A, Machtei EE, Giladi HZ. Biocompatibility and osteoconductivity of PLCL coated and noncoated xenografts: An in vitro and preclinical trial. Clin Implant Dent Relat Res. 2018; 20(3): 294-299. doi: 10.1111/cid.12596Mayer Y, Ginesin O, Khutaba A, Machtei EE, Giladi HZ. Biocompatibility and osteoconductivity of PLCL coated and noncoated xenografts: An in vitro and preclinical trial. Clin Implant Dent Relat Res. 2018; 20(3): 294-299. doi: 10.1111/cid.12596Qiao W, Liu R, Li Z, Luo X, Huang B, Liu Q, Chen Z, Tsoi JKH, Su Y-X, Cheung KMC, Matinlinna JP, Yeung KWK, Chen Z. Contribution of the in situ release of endogenous cations from xenograft bone driven by fluoride incorporation toward enhanced bone regeneration. Biomater Sci. 2018; 6(11): 2951-2964. doi: 10.1039/c8bm00910dQiao W, Liu R, Li Z, Luo X, Huang B, Liu Q, Chen Z, Tsoi JKH, Su Y-X, Cheung KMC, Matinlinna JP, Yeung KWK, Chen Z. Contribution of the in situ release of endogenous cations from xenograft bone driven by fluoride incorporation toward enhanced bone regeneration. Biomater Sci. 2018; 6(11): 2951-2964. doi: 10.1039/c8bm00910dArpağ OF, Damlar I, Altan A, Tatli U, Günay A. To what extent does hyaluronic acid affect healing of xenografts? A histomorphometric study in a rabbit model. J Appl Oral Sci. 2018; 26: 20170004. doi: 10.1590/1678-7757-2017-0004Arpağ OF, Damlar I, Altan A, Tatli U, Günay A. To what extent does hyaluronic acid affect healing of xenografts? A histomorphometric study in a rabbit model. J Appl Oral Sci. 2018; 26: 20170004. doi: 10.1590/1678-7757-2017-0004Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes (Review). Expert Review of Medical Devices. 2006; 3(1): 49-57. doi: 10.1586/17434440.3.1.49.Laurencin C, Khan Y, El-Amin SF. Bone graft substitutes (Review). Expert Review of Medical Devices. 2006; 3(1): 49-57. doi: 10.1586/17434440.3.1.49.Ma D, Ren L, Liu Y, Chen F, Zhang J, Xue Z, Mao T. Engineering scaffold-free bone tissue using bone marrow stromal cell sheets. J Orthop Res. 2010; 28(5): 697-702. doi: 10.1002/jor.21012Ma D, Ren L, Liu Y, Chen F, Zhang J, Xue Z, Mao T. Engineering scaffold-free bone tissue using bone marrow stromal cell sheets. J Orthop Res. 2010; 28(5): 697-702. doi: 10.1002/jor.21012Diaz-Rodriguez P, López-Álvarez M, Serra J, González P, Landín M. Current stage of marine ceramic grafts for 3D bone tissue regeneration. Mar Drugs. 2019; 17(8): 471. doi: 10.3390/md17080471Diaz-Rodriguez P, López-Álvarez M, Serra J, González P, Landín M. Current stage of marine ceramic grafts for 3D bone tissue regeneration. Mar Drugs. 2019; 17(8): 471. doi: 10.3390/md17080471Fu K, Xu Q, Czernuszka J, Triffitt JT, Xia Z. Characterization of a biodegradable coralline hydroxyapatite/calcium carbonate composite and its clinical implementation. Biomed Mater. 2013; 8(6): 065007. doi: 10.1088/1748-6041/8/6/065007Fu K, Xu Q, Czernuszka J, Triffitt JT, Xia Z. Characterization of a biodegradable coralline hydroxyapatite/calcium carbonate composite and its clinical implementation. Biomed Mater. 2013; 8(6): 065007. doi: 10.1088/1748-6041/8/6/065007Zhang G, Brion A, Willemin A-S, Piet M-H, Moby V, Bianchi A, Mainard D, Galois L, Gillet P, Rousseau M. Nacre, a natural, multi-use, and timely biomaterial for bone graft substitution. J Biomed Mater Res A. 2017; 105(2): 662-671. doi: 10.1002/jbm.a.35939Zhang G, Brion A, Willemin A-S, Piet M-H, Moby V, Bianchi A, Mainard D, Galois L, Gillet P, Rousseau M. Nacre, a natural, multi-use, and timely biomaterial for bone graft substitution. J Biomed Mater Res A. 2017; 105(2): 662-671. doi: 10.1002/jbm.a.35939Шаманская Т.В., Осипова Е.Ю., Румянцев С.А. Технологии культивирования мезенхимальных стволовых клеток ex vivo для клинического использования. Онкогематология. 2009; 3: 69-76.Shamanskaya TV, Osipova EYu, Rumyantsev SA. Ex vivo mesenchymal stem cell culture technologies for clinical use. Onkogematologiya. 2009; 3: 69-76. (In Russ.)Koga H, Engebretsen L, Brinchmann JE, Muneta T, Sekiya I. Mesenchymal stem cell-based therapy for cartilage repair: A review. Knee Surg Sports Traumatol Arthrosc. 2009; 17(11): 1289-1297. doi: 10.1007/s00167-009-0782-4Koga H, Engebretsen L, Brinchmann JE, Muneta T, Sekiya I. Mesenchymal stem cell-based therapy for cartilage repair: A review. Knee Surg Sports Traumatol Arthrosc. 2009; 17(11): 1289-1297. doi: 10.1007/s00167-009-0782-4Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976; 4: 267-274.Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976; 4: 267-274.Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9: 641-650.Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9: 641-650.Лупатов А.Ю., Вдовин А.С., Вахрушев И.В., Полтавцева Р.А., Ярыгин К.Н. Сравнительный анализ экспрессии поверхностных маркеров на фибробластах и фибробластоподобных клетках, выделенных из различных тканей человека. Клеточные технологии в биологии и медицине. 2014; 4: 221-228.Lupatov AYu, Vdovin AS, Vakhrushev IV, Poltavtseva RA, Yarygin KN. Comparative analysis of the expression of surface markers on fibroblasts and fibroblast-like cells isolated from various human tissues. Kletochnye tekhnologii v biologii i meditsine. 2014; 4: 221-228. (In Russ.)Shurygin MG, Shurygina IA, Dremina NN, Kanya OV. Endogenous progenitors as the source of cell material for ischemic damage repair in experimental myocardial infarction under conditions of changed concentration of vascular endothelial growth factor. Bulletin of Experimental Biology and Medicine. 2015; 158(4): 528-531.Shurygin MG, Shurygina IA, Dremina NN, Kanya OV. Endogenous progenitors as the source of cell material for ischemic damage repair in experimental myocardial infarction under conditions of changed concentration of vascular endothelial growth factor. Bulletin of Experimental Biology and Medicine. 2015; 158(4): 528-531.Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110(10): 3499-3506. doi: 10.1182/blood-2007-02-069716Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110(10): 3499-3506. doi: 10.1182/blood-2007-02-069716Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018; 93(1): 19- 31. doi: 10.1002/cyto.a.23242Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018; 93(1): 19-31. doi: 10.1002/cyto.a.23242Kolaparthy LK, Sanivarapu S, Moogla S, Kutcham RS. Adipose tissue‐adequate, accessible regenerative material. Int J Stem Cells. 2015; 8: 121-127.Kolaparthy LK, Sanivarapu S, Moogla S, Kutcham RS. Adipose tissue‐adequate, accessible regenerative material. Int J Stem Cells. 2015; 8: 121-127.Peng L, Li H, Gu L, Peng X-M, Huang Y-S, Gao Z-L. Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults. World J Gastroenterol. 2007; 13(11): 1743-1746. doi: 10.3748/wjg.v13.i11.1743Peng L, Li H, Gu L, Peng X-M, Huang Y-S, Gao Z-L. Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults. World J Gastroenterol. 2007; 13(11): 1743-1746. doi: 10.3748/wjg.v13.i11.1743Seebach C, Henrich D, Tewksbury R, Wilhelm K, Marzi I. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions. Calcif Tissue Int. 2007; 80(4): 294-300. doi: 10.1007/s00223-007-9020-6Seebach C, Henrich D, Tewksbury R, Wilhelm K, Marzi I. Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions. Calcif Tissue Int. 2007; 80(4): 294-300. doi: 10.1007/s00223-007-9020-6Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003; 33(6): 919-926. doi: 10.1016/j.bone.2003.07.005Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003; 33(6): 919-926. doi: 10.1016/j.bone.2003.07.005Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003; 116(9): 1827-1835. doi: 10.1242/jcs.00369Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003; 116(9): 1827-1835. doi: 10.1242/jcs.00369Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-317. doi: 10.1080/14653240600855905Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-317. doi: 10.1080/14653240600855905Ning H, Lin G, Lue TF, Lin C-S. Mesenchymal stem cell marker Stro-1 is a 75kd endothelial antigen. Biochem Biophys Res Commun. 2011; 413(2): 353-357. doi: 10.1016/j.bbrc.2011.08.104Ning H, Lin G, Lue TF, Lin C-S. Mesenchymal stem cell marker Stro-1 is a 75kd endothelial antigen. Biochem Biophys Res Commun. 2011; 413(2): 353-357. doi: 10.1016/j.bbrc.2011.08.104Nakamura A, Akahane M, Shigematsu H, Tadokoro M, Morita Y, Ohgushi H, Dohi Y, Imamura T. Cell sheet transplantation of cultured mesenchymal stem cells enhances bone formation in a rat nonunion model. Bone. 2010; 46(2): 418-424. doi: 10.1016/j.bone.2009.08.048Nakamura A, Akahane M, Shigematsu H, Tadokoro M, Morita Y, Ohgushi H, Dohi Y, Imamura T. Cell sheet transplantation of cultured mesenchymal stem cells enhances bone formation in a rat nonunion model. Bone. 2010; 46(2): 418-424. doi: 10.1016/j.bone.2009.08.048Yim RL-H, Lee JT-Y, Bow CH, Meij B, Leung V, Cheung KMC, Vavken P, Samartzis D. A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: Insights and future directions for regenerative therapeutics. Stem Cells Dev. 2014; 23(21): 2553-2567. doi: 10.1089/scd.2014.0203Yim RL-H, Lee JT-Y, Bow CH, Meij B, Leung V, Cheung KMC, Vavken P, Samartzis D. A systematic review of the safety and efficacy of mesenchymal stem cells for disc degeneration: Insights and future directions for regenerative therapeutics. Stem Cells Dev. 2014; 23(21): 2553-2567. doi: 10.1089/scd.2014.0203Shimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials. 2003; 24(13): 2309-2316. doi: 10.1016/s0142-9612(03)00110-8Shimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials. 2003; 24(13): 2309-2316. doi: 10.1016/s0142-9612(03)00110-8Owaki T, Shimizu T, Yamato M, Okano T. Cell sheet engineering for regenerative medicine: Current challenges and strategies. Biotechnol J. 2014; 9(7): 904-914. doi: 10.1002/biot.201300432Owaki T, Shimizu T, Yamato M, Okano T. Cell sheet engineering for regenerative medicine: Current challenges and strategies. Biotechnol J. 2014; 9(7): 904-914. doi: 10.1002/biot.201300432Радеева И.Ф., Думченко Н.Б., Нечаева Е.А. Культивирование клеток на микроносителях в биореакторах. Вестник ПНИПУ. Химическая технология и биотехнология. 2019; 2: 22-32. doi: 10-15593/2224-9400/2019.2.02Radeeva IF, Dumchenko NB, Nechaeva EA. Cell culture on microcarriers in bioreactors. Vestnik PNIPU. Khimicheskaya tekhnologiya i biotekhnologiya. 2019; 2: 22-32. doi: 10-15593/2224-9400/2019.2.02Kwon OH, Kikuchi A, Yamato M, Sakurai Y, Okano T. Rapid cell sheet detachment from poly(N- isopropylacrylamide)-grafted porous cell culture membranes. J Biomed Mater Res. 2000; 50(1): 82-89. doi: 10.1002/(sici)1097-4636(200004)50:1<82::aidjbm12>3.0.co;2-7Kwon OH, Kikuchi A, Yamato M, Sakurai Y, Okano T. Rapid cell sheet detachment from poly(N-isopropylacrylamide)-grafted porous cell culture membranes.J Biomed Mater Res. 2000; 50(1): 82-89. doi: 10.1002/(sici)1097-4636(200004)50:1<82::aid-jbm12>3.0.co;2-7Calve S, Dennis RG, Kosnik PE, Baar K, Grosh K, Arruda EM. Engineering of functional tendon. Tissue Eng. 2004; 10(5-6): 755-761. doi: 10.1089/1076327041348464Calve S, Dennis RG, Kosnik PE, Baar K, Grosh K, Arruda EM. Engineering of functional tendon. Tissue Eng. 2004; 10(5-6): 755-761. doi: 10.1089/1076327041348464Murdoch AD, Grady LM, Ablett MP, Katopodi T, Meadows RS, Hardingham TE. Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Stem Cells. 2007; 25(11): 2786-2796. doi: 10.1634/stemcells.2007-0374Murdoch AD, Grady LM, Ablett MP, Katopodi T, Meadows RS, Hardingham TE. Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of scaffold-free cartilage. Stem Cells. 2007; 25(11): 2786-2796. doi: 10.1634/stemcells.2007-0374Sakaguchi K, Shimizu T, Okano T. Construction of three-dimensional vascularized cardiac tissue with cell sheet engineering. J Control Release. 2015; 205: 83-88. doi: 10.1016/j.jconrel.2014.12.016Sakaguchi K, Shimizu T, Okano T. Construction of threedimensional vascularized cardiac tissue with cell sheet engineering. J Control Release. 2015; 205: 83-88. doi: 10.1016/j.jconrel.2014.12.016L’Heureux N, McAllister TN, de la Fuente LM. Tissueengineered blood vessel for adult arterial revascularization. N Engl J Med. 2007; 357(14): 1451-1453. doi: 10.1056/NEJMc071536L’Heureux N, McAllister TN, de la Fuente LM. Tissueengineered blood vessel for adult arterial revascularization. N Engl J Med. 2007; 357(14): 1451-1453. doi: 10.1056/NEJMc071536Masuda S, Shimizu T, Yamato M, Okano T. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev. 2008; 60(2): 277-285. doi: 10.1016/j.addr.2007.08.031Masuda S, Shimizu T, Yamato M, Okano T. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev. 2008; 60(2): 277-285. doi: 10.1016/j.addr.2007.08.031Bornes TD, Adesida AB, Jomha NM. Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review. Arthritis Res Ther. 2014; 16(5): 432. doi: 10.1186/s13075-014-0432-1Bornes TD, Adesida AB, Jomha NM. Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review. Arthritis Res Ther. 2014; 16(5): 432. doi: 10.1186/s13075-014-0432-1Lubis AMT, Lubis VK. Adult bone marrow stem cells in cartilage therapy. Acta Medica Indonesiana. 2012; 44(1): 62-68.Lubis AMT, Lubis VK. Adult bone marrow stem cells in cartilage therapy. Acta Medica Indonesiana. 2012; 44(1): 62-68.Gudas R, Gudaite A, Pocius A, Gudiene A, Cekanauskas E, Monastyreckiene E, Basevicius A. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am J Sports Med. 2012; 40(11): 2499-508. doi: 10.1177/0363546512458763Gudas R, Gudaite A, Pocius A, Gudiene A, Cekanauskas E, Monastyreckiene E, Basevicius A. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am J Sports Med. 2012; 40(11): 2499-508. doi: 10.1177/0363546512458763Levy YD, Görtz S, Pulido PA, McCauley JC, Bugbee WD. Do fresh osteochondral allografts successfully treat femoral condyle lesions? Clin Orthop Relat Res. 2013; 471(1): 231-237. doi: 10.1007/s11999-012-2556-4Levy YD, Görtz S, Pulido PA, McCauley JC, Bugbee WD. Do fresh osteochondral allografts successfully treat femoral condyle lesions? Clin Orthop Relat Res. 2013; 471(1): 231-237. doi: 10.1007/s11999-012-2556-4Kon E, Filardo G, Berruto M, Benazzo F, Zanon G, Villa SD, Marcacci M. Articular cartilage treatment in high-level male soccer players: A prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture. Am J Sports Med. 2011; 39(12): 2549-2557. doi: 10.1177/0363546511420688Kon E, Filardo G, Berruto M, Benazzo F, Zanon G, Villa SD, Marcacci M. Articular cartilage treatment in high-level male soccer players: A prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture. Am J Sports Med. 2011; 39(12): 2549-2557. doi: 10.1177/0363546511420688Chavez RD, Serra R. Scaffoldless tissue-engineered cartilage for studying transforming growth factor beta- mediated cartilage formation. Biotechnol Prog. 2020; 36(1): 2897. doi: 10.1002/btpr.289765 Chavez RD, Serra R. Scaffoldless tissue-engineered cartilage for studying transforming growth factor beta-mediated cartilage formation. Biotechnol Prog. 2020; 36(1): 2897. doi: 10.1002/btpr.2897Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238: 265-272. doi: 10.1006/excr.1997.3858Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238: 265-272. doi: 10.1006/excr.1997.3858Tew SR, Murdoch AD, Rauchenberg RP, Hardingham TE. Cellular methods in cartilage research: Primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods. 2008; 45(1): 2–9. doi: 10.1016/j.ymeth.2008.01.006Tew SR, Murdoch AD, Rauchenberg RP, Hardingham TE. Cellular methods in cartilage research: Primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods. 2008; 45(1): 2–9. doi: 10.1016/j.ymeth.2008.01.006Szychlinska MA, Calabrese G, Ravalli S, Parrinello NL, Forte S, Castrogiovanni P, Pricoco E, Imbesi R, Castorina S, Leonardi R, Rosa MD, Musumeci G. Cycloastragenol as an exogenous enhancer of chondrogenic differentiation of human adiposederived mesenchymal stem cells. A morphological study. Cells. 2020; 9(2): 347. doi: 10.3390/cells9020347Szychlinska MA, Calabrese G, Ravalli S, Parrinello NL, Forte S, Castrogiovanni P, Pricoco E, Imbesi R, Castorina S, Leonardi R, Rosa MD, Musumeci G. Cycloastragenol as an exogenous enhancer of chondrogenic differentiation of human adiposederived mesenchymal stem cells. A morphological study. Cells. 2020; 9(2): 347. doi: 10.3390/cells9020347Cooke ME, Allon AA, Cheng T, Kuo AC, Kim HT, Vail TP, Marcucio RS, Schneider RA, Lotz JC, Alliston T. Structured three-dimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis Cartilage. 2011; 19(10): 1210-1218. doi: 10.1016/j.joca.2011.07.005Cooke ME, Allon AA, Cheng T, Kuo AC, Kim HT, Vail TP, Marcucio RS, Schneider RA, Lotz JC, Alliston T. Structured threedimensional co-culture of mesenchymal stem cells with chondrocytes promotes chondrogenic differentiation without hypertrophy. Osteoarthritis Cartilage. 2011; 19(10): 1210-1218. doi: 10.1016/j.joca.2011.07.005

The authors declare that there are no conflicts of interest present.